APA (7th ed.) Citation

Seki, R., Ohta, A., Niwa, A., Sugimine, Y., Naito, H., Nakahata, T., & Saito, M. K. (2021). Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Seki, Ryosuke, Akira Ohta, Akira Niwa, Yoshinori Sugimine, Haruna Naito, Tatsutoshi Nakahata, and Megumu K. Saito. Correction: Induced Pluripotent Stem Cell-derived Monocytic Cell Lines from a NOMID Patient Serve as a Screening Platform for Modulating NLRP3 Inflammasome Activity. Public Library of Science (PLoS), 2021.

MLA (9th ed.) Citation

Seki, Ryosuke, et al. Correction: Induced Pluripotent Stem Cell-derived Monocytic Cell Lines from a NOMID Patient Serve as a Screening Platform for Modulating NLRP3 Inflammasome Activity. Public Library of Science (PLoS), 2021.